Poorly differentiated gastroenteropancreatic neuroendocrine carcinomas are aggressive
neoplasms of challenging clinical management. A small proportion of patients with early …

Neuroendocrine neoplasms (NENs), which are characterized by neuroendocrine
differentiation, can arise in various organs. NENs have been divided into well-differentiated …

This ENETS guidance paper, developed by a multidisciplinary working group, provides up‐
to‐date and practical advice on the diagnosis and management of digestive neuroendocrine …

Background There is no standard second-line treatment after platinum–etoposide
chemotherapy for gastroenteropancreatic neuroendocrine carcinoma. We aimed to evaluate …

Neuroendocrine tumors (NETs) are rare neoplasms with a wide spectrum of clinical
behavior, from the long survival of well-differentiated NETs to the dismal prognosis of high …

Neuroendocrine neoplasms (NENs) are rare heterogeneous tumors that can develop in
almost any organ, with the digestive organs, including the gastrointestinal tract and …

Immunotherapy has revolutionised the treatment of oncological patients, but its application
in various endocrine tumours is rather limited and is mainly used when conventional …

Background: Gastroenteropancreatic (GEP) neuroendocrine neoplasms with Ki-67> 20%
were subdivided in the most recent 2019 World Health Organization histopathological …

Simple Summary The development of new treatments for patients with neuroendocrine
neoplasms (NENs) is imperative. Immunotherapy has shown efficacy in various neoplasms …

Neuroendocrine neoplasms (NENs) are a heterogeneous family of tumors of challenging
diagnosis and clinical management. Their incidence and prevalence continue to rise mainly …